Dogwood Therapeutics (DWTX)
NASDAQ:DWTX
US Market
Holding DWTX?
Track your performance easily

Dogwood Therapeutics (DWTX) Financial Statements

117 Followers

Dogwood Therapeutics Financial Overview

Dogwood Therapeutics's market cap is currently ―. The company's EPS TTM is $-5.871; its P/E ratio is -0.76; Dogwood Therapeutics is scheduled to report earnings on November 11, 2024, and the estimated EPS forecast is $-1.25. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -1.05M$ -1.31M$ -1.14M$ -1.27M$ -1.44M
EBITDA$ -1.05M$ -1.31M$ -1.14M$ -1.27M$ -1.44M
Net Income Common Stockholders$ -1.05M$ -1.29M$ -1.10M$ -1.24M$ -1.44M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.02M$ 2.38M$ 3.32M$ 4.79M$ 4.59M
Total Assets$ 3.64M$ 3.22M$ 4.17M$ 5.25M$ 5.21M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -3.02M$ -2.38M$ -3.32M$ -4.79M$ -4.59M
Total Liabilities$ 500.08K$ 570.08K$ 358.55K$ 487.14K$ 520.03K
Stockholders Equity$ 3.14M$ 2.65M$ 3.81M$ 4.76M$ 4.69M
Cash Flow-
Free Cash Flow$ -811.75K$ -937.41K$ -1.47M$ -960.45K$ -742.41K
Operating Cash Flow$ -811.75K$ -937.41K$ -1.47M$ -960.45K$ -742.41K
Investing Cash Flow-----
Financing Cash Flow$ 1.45M--$ 1.16M-
Currency in USD

Dogwood Therapeutics Earnings and Revenue History

Dogwood Therapeutics Debt to Assets

Dogwood Therapeutics Cash Flow

Dogwood Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis